ACTG A5229 (VS 10):TRIAL OF URIDINE SUPPLEMENTATION IN HIV LIPOATROPHY

ACTG A5229（VS 10）：补充尿苷治疗 HIV 脂肪萎缩的试验

• 批准号: 7719530
• 负责人: LISA A. KOSMISKI
• 金额: $ 0.05万
• 依托单位: UNIVERSITY OF COLORADO DENVER
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-04-01 至 2008-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7719530
• 关键词: AIDS clinical trial group; Buttocks; Computer Retrieval of Information on Scientific Projects Database; Europe; Face; Fatty acid glycerol esters; Food Supplements; Funding; Grant; HIV; Institution; Juice; Leg; Lipoatrophy; Milk; Nutritional; Persons; Pharmaceutical Preparations; Powder dose form; Research; Research Personnel; Resources; Source; Supplementation; United States Food and Drug Administration; United States National Institutes of Health; Upper arm; Uridine; Water

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study will try to see if taking a uridine supplement, NucleomaxX¿, is safe in HIV-infected persons and if it will reverse loss of fat in the face, arms, legs, or buttocks. The study will also try to see how well the study drug is tolerated. The study drug is a powdered nutritional food supplement that contains a substance called uridine. It comes in a sachet (packet) and needs to be mixed in with juice, milk, or water. The study drug is used in Europe as a food supplement but is not approved by the U.S. Food and Drug Administration (FDA) and is considered an experimental drug in the U.S.

这个子项目是众多研究子项目之一